Everist Genomics Ann Arbor, MI - 48108

Everist Genomics is categorized under Diagnostic Substances in Ann Arbor, MI and active since 2012.

Everist Genomics was established in 2012, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Diagnostic Substances business, which does work in the B2B market, and is classified as a Diagnostic Substances, under code number 3254120 by the NAICS.

If you are seeking more information, feel free to contact Thomas Everist, Chief Executive Officer at the company’s single location by writing to 709 West Ellsworth Road, Ann Arbor, Michigan MI 48108 or by phoning (734) 929-9475. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Everist Genomics
Contact Person: Thomas Everist, Chief Executive Officer
Address: 709 West Ellsworth Road, Ann Arbor, Michigan 48108
Phone Number: (734) 929-9475
Website Address: everistgenomics.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Diagnostic Substances
SIC Code: 2835
NAICS Code: 3254120
Share This Business:

Everist Genomics was started in 2012 to provide professional Diagnostic Substances under the SIC code 2835 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Thomas Everist, Chief Executive Officer for inquiries that concern Everist Genomics by calling the company number (734) 929-9475, as your correspondence is most welcome. Additionally, the physical location of the single location of Everist Genomics can be found at the coordinates 42.22934,-83.73951 as well as the street address 709 West Ellsworth Road in Ann Arbor, Michigan 48108.

For its online presence, you may visit Everist Genomics’s website at everistgenomics.com and engage with its social media outlets through on Twitter and on Facebook.